Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
Recruitment status was Not yet recruiting
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This research study is studying at biomarkers in tissue samples from patients with stage I or stage III endometrial cancer.
Genetic: RNA analysis
Genetic: microarray analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: laboratory biomarker analysis
|Official Title:||Micro RNA's Associated With Lymph Node Metastasis in Endometrial Cancer|
- Association between microRNA expression and lymph node metastasis [ Designated as safety issue: No ]
|Study Start Date:||May 2010|
|Estimated Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|
- To identify microRNA expression patterns associated with lymph node metastasis in samples from patients with endometrial cancer.
OUTLINE: Banked tumor tissue specimens are analyzed for microRNA expression profiling by microarray analysis and reverse transcriptase-PCR assays.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01119573
|Principal Investigator:||David S. Miller, MD||Simmons Cancer Center|